Contact your GP, specialist, or clinical trial team promptly if you experience: A spreading rash , hives (urticaria), or widespread skin redness that develops after starting treatment Swelling of the face, lips, tongue, or throat , which may indicate angioedema a potentially serious allergic reaction requiring urgent assessment Difficulty breathing or swallowing alongside skin changes call 999 immediately , as this could indicate anaphylaxis Signs of infection at an injection site , including increasing warmth, pus, significant swelling, or fever Persistent or worsening skin symptoms that do not improve with basic self-care measures after one to two weeks Unexplained bruising or bleeding beyond what would be expected from a subcutaneous injection If you are unsure whether your symptoms require urgent attention, NHS 111 can provide guidance

Several markers were increased across all groups compared to controls including IL-1RA, IL-1, bFGF and IL-13, while IL-9 was the only cytokine decreased in all groups (Fig
A warning letter is a formal compliance notice, not a recall or a closure order
A problem in one area, like your gut's ability to absorb nutrients or your body's mineral balance, can send ripple effects straight to your heart's rhythm
Blood Sugar Results in Type 2 Diabetes In the SOLSTICE Phase 2b trial, adults with type 2 diabetes experienced significant improvements in glucose control